| CTRI Number |
CTRI/2025/12/098365 [Registered on: 03/12/2025] Trial Registered Prospectively |
| Last Modified On: |
23/11/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
“A study comparing injection-based treatment (hyaluronic acid) and routine physiotherapy exercises on knee pain and inflammation in patients with knee osteoarthritis. |
|
Scientific Title of Study
|
Comparison of Effect on Serum Inflammatory Markers Following Viscosupplementation Versus Conventional Management in Knee Osteoarthritis |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Ishita |
| Designation |
PG Resident |
| Affiliation |
VMMC and Safdarjung hospital |
| Address |
Room No. 27, Department of Physical Medicine and Rehabilitation,
Vardhman Mahavir Medical College and Safdarjung Hospital,
Ring Roada South DELHI 110029 India |
| Phone |
9899675868 |
| Fax |
|
| Email |
ishitaladha3@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Ajay Gupta |
| Designation |
Director Professor& Head of Department |
| Affiliation |
Vardhman Mahavir Medical College and Safdarjung hospital |
| Address |
Room No. 27, Department of Physical Medicine and Rehabilitation,
Vardhman Mahavir Medical College and Safdarjung Hospital,
Ring Roada
South DELHI 110029 India |
| Phone |
9899675868 |
| Fax |
|
| Email |
dragupta2013@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Ishita |
| Designation |
PG Resident |
| Affiliation |
VMMC and Safdarjung hospital |
| Address |
Room No. 27, Department of Physical Medicine and Rehabilitation,
Vardhman Mahavir Medical College and Safdarjung Hospital,
Ring Roada
South DELHI 110029 India |
| Phone |
9899675868 |
| Fax |
|
| Email |
ishitaladha3@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
Vardhman Mahavir Medical College and Safdarjung Hospital |
| Address |
Department of Physical Medicine and Rehabilitation,
Ring Road (Near AIIMS),
New Delhi – 110029,
Delhi, India. |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Ishita Ladha |
VMCC and Safdarjung Hospital |
H693+H6W NH 48 near AIIMS Hospital Ansari Nagar West New Delhi Delhi 110029 New Delhi DELHI |
09899675868
ishitaladha3@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Ethics committee of VMMC and safdarjung Hospital |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Healthy Human Volunteers |
• Patients of either gender, diagnosed with primary OA knee of tibio- femoral joint as defined by ACR clinical and radiographic criteria. |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Conventional Management (Non-viscosupplementation) |
Participants in the comparator arm will receive conventional management comprising isometric quadriceps and hamstrings strengthening exercises, physical modalities (such as deep heat therapy), topical analgesics, and paracetamol 1000 mg SOS.” |
| Intervention |
Intra-articular High Molecular Weight Hyaluronic Acid (HMW-HA) |
Participants in the intervention arm will receive a single intra-articular injection of High Molecular Weight Hyaluronic Acid (90 mg/3 mL) into the affected knee under aseptic precautions, along with isometric quadriceps and hamstrings strengthening exercises for 4 weeks |
|
|
Inclusion Criteria
|
| Age From |
30.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Adults of either gender with primary tibiofemoral knee osteoarthritis fulfilling ACR clinical and radiographic criteria, radiographic Kellgren Lawrence grade II or III, and body mass index less than 40, who are willing to provide written informed consent. |
|
| ExclusionCriteria |
| Details |
History of bleeding disorders; any acute injury or recent surgery within the past three months; use of anti-inflammatory drugs for more than seven days in the past four weeks or within five days before starting the trial; current use of corticosteroids or immunosuppressive drugs; presence of any acute co-existing illness; prior hyaluronic acid injection or unwillingness to receive hyaluronic acid; any overlying skin infection; venous or lymphatic stasis. |
|
|
Method of Generating Random Sequence
|
Random Number Table |
|
Method of Concealment
|
An Open list of random numbers |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| NIL |
NIL |
|
|
Target Sample Size
|
Total Sample Size="118" Sample Size from India="118"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 4 |
|
Date of First Enrollment (India)
|
10/01/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="3" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Osteoarthritis of the knee is a common degenerative joint disorder associated with cartilage degradation and low grade inflammation leading to pain and functional limitation. Intra articular hyaluronic acid injection, also known as viscosupplementation, is used to improve joint lubrication and has shown potential anti inflammatory effects. This randomized comparative trial aims to compare the effect of viscosupplementation versus conventional management on serum inflammatory markers interleukin 6 and tumor necrosis factor alpha as well as functional outcomes in patients with primary knee osteoarthritis. A total of 118 participants fulfilling American College of Rheumatology clinical and radiographic criteria for grade II or III knee osteoarthritis will be randomly assigned into two groups. The study group will receive a single intra articular injection of high molecular weight hyaluronic acid along with exercise therapy, while the control group will receive exercise therapy and physical modalities only. Serum interleukin 6, tumor necrosis factor alpha, Knee Injury and Osteoarthritis Outcome Score, and physical performance tests will be assessed at baseline and after four weeks of intervention to evaluate changes in inflammatory markers and physical function. |